Spruce Biosciences Inc. (SPRB)
NASDAQ · Healthcare
Spruce Biosciences Inc. EBITDA 2022–2025
Spruce Biosciences Inc. annual/quarterly ebitda history and growth rate from 2022 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Spruce Biosciences Inc. ebitda for the quarter ending March 31, 2025 was -14.5 M, a 14.80% increase year-over-year.
- Spruce Biosciences Inc. ebitda for the twelve months ending March 31, 2025 was -52.0 M.
- Spruce Biosciences Inc. annual ebitda for 2025 was -36.5 M, a 34.96% decrease from 2024.
- Spruce Biosciences Inc. annual ebitda for 2024 was -56.1 M, a 8.05% increase from 2023.
- Spruce Biosciences Inc. annual ebitda for 2023 was -51.9 M, a 9.99% increase from 2022.
- Spruce Biosciences Inc. annual ebitda for 2022 was -47.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Spruce Biosciences Inc. EBITDA — FAQ
Spruce Biosciences Inc. (SPRB) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SPRB's ebitda history?
The chart and table above show Spruce Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.